A Phase 1/2 Dose Escalation and Expansion Study of BE-101 forthe Treatment of Adults with Moderately Severe or Severe Hemophilia BA Phase 1/2 Dose Escalation and Expansion Study of BE-101 for...

Project: Research project

Project Details

Description

A Phase 1/2 Dose Escalation and Expansion Study of BE-101 for the Treatment of Adults with Moderately Severe or Severe Hemophilia B A Phase 1/2 Dose Escalation and Expansion Study of BE-101 for...
StatusActive
Effective start/end date6/10/24 → 6/9/35

Funding

  • BE BIOPHARMA, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint